UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 58

Sortiert nach

Pretransplantation [18‐F]fluorodeoxyglucose positron emission tomography scan predicts outcome in patients with recurrent Hodgkin lymphoma or aggressive non‐Hodgkin lymphoma undergoing reduced‐intensity conditioning followed by allogeneic stem cell transplantation

Cancer, 2010-11, Vol.116 (21), p.5001-5011

2010

Link zum Volltext

Verfügbarkeit prüfen

Serum-soluble tumor necrosis factor receptor 2 (sTNF-R2) level determines clinical outcome in patients with aggressive non-Hodgkin's lymphoma

European journal of haematology, 2006-09, Vol.77 (3), p.217-225

2006

Link zum Volltext

Verfügbarkeit prüfen

Clinical characteristics and outcome of isolated extracerebral relapses of primary central nervous system lymphoma: a case series

Hematological oncology, 2011-03, Vol.29 (1), p.10-16

2011

Link zum Volltext

Verfügbarkeit prüfen

A prospective study of P-IMVP-16/CBDCA: a novel salvage chemotherapy for patients with aggressive non-Hodgkin's lymphoma who had previously received CHOP therapy as first-line chemotherapy

European journal of haematology, 2002-06, Vol.68 (6), p.354-361

2002

Link zum Volltext

Verfügbarkeit prüfen

Central nervous system occurrence in elderly patients with aggressive lymphoma and a long-term follow-up

Annals of oncology, 2007-06, Vol.18 (6), p.1085-1089

2007

Link zum Volltext

Verfügbarkeit prüfen

Treatment of intermediate- and high-grade non-Hodgkin's lymphoma using CEOP versus CNOP

European journal of haematology, 2002-03, Vol.68 (3), p.135-143

2002

Link zum Volltext

Verfügbarkeit prüfen

Autologous stem cell transplantation in first-line treatment of high-risk aggressive non-Hodgkin's lymphoma

Neoplasma, 2008, Vol.55 (2), p.107

2008

Link zum Volltext

Verfügbarkeit prüfen

Outcome of Elderly Patients with Aggressive Non-Hodgkin's Lymphoma Refractory to or Relapsing after First-line CHOP or CHOP-like Chemotherapy: A Low Probability of Cure

Leukemia & lymphoma, 2004-07, Vol.45 (7), p.1391-1394

2004

Link zum Volltext

Verfügbarkeit prüfen

Impact of involved field radiotherapy in partial response after doxorubicin-based chemotherapy for advanced aggressive non-Hodgkin’s lymphoma

International journal of radiation oncology, biology, physics, 2006-11, Vol.66 (4), p.1168-1177

2006

Link zum Volltext

Verfügbarkeit prüfen

Frontline Therapy with Early Intensification and Autologous Stem Cell Transplantation versus Conventional Chemotherapy in Unselected High-Risk, Aggressive Non-Hodgkin’s Lymphoma Patients: A Prospective Randomized GEMOH Report

Acta haematologica, 2006-01, Vol.115 (1-2), p.15-21

2006

Link zum Volltext

Verfügbarkeit prüfen

Midtreatment 18F‐fluorodeoxyglucose positron‐emission tomography in aggressive non‐Hodgkin lymphoma

Cancer, 2011-03, Vol.117 (5), p.1010-1018

2011

Link zum Volltext

Verfügbarkeit prüfen

The value of radiation therapy in the management of aggressive non-Hodgkin's lymphomas

Onkologie, 2002-06, Vol.25 (3), p.214-220

2002

Link zum Volltext

Verfügbarkeit prüfen

Dose-dense therapy improves survival in aggressive non-Hodgkin’s lymphoma

Annals of hematology, 2010-03, Vol.89 (3), p.273-282

2010

Link zum Volltext

Verfügbarkeit prüfen

Combination chemotherapy with adriamycin, cyclophosphamide, vincristine, methotrexate, etoposide and dexamethasone (ACOMED) followed by involved field radiotherapy induces high remission rates and durable long-term survival in patients with aggressive malignant non-Hodgkin's lymphomas: long-term follow-up of a pilot study

Leukemia & lymphoma, 2005-12, Vol.46 (12), p.1729-1734

2005

Link zum Volltext

Verfügbarkeit prüfen

Prognostic factors in localized aggressive non-Hodgkin's lymphoma

American journal of clinical oncology, 2003-02, Vol.26 (1), p.1-5

2003

Link zum Volltext

Verfügbarkeit prüfen

Treatment outcome in elderly patients with aggressive non-Hodgkin's lymphoma

Rinshō ketsueki, 2000-07, Vol.41 (7), p.568

2000

Link zum Volltext

Verfügbarkeit prüfen

High-dose therapy followed by stem cell transplantation in partial response after first-line induction therapy for aggressive non-Hodgkin's lymphoma

Annals of oncology, 1998, Vol.9 (suppl-1), p.S5-S8

1998

Link zum Volltext

Verfügbarkeit prüfen

Allogeneic Stem Cell Transplantation for Patients with Relapsed Chemorefractory Aggressive Non-Hodgkin Lymphomas

Biology of blood and marrow transplantation, 2009-05, Vol.15 (5), p.547-553

2009

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Follow-Up of Tandem High-Dose Therapy with Autologous Stem Cell Support for Adults with High-Risk Age-Adjusted International Prognostic Index Aggressive non-Hodgkin Lymphomas: A GOELAMS Pilot Study

Biology of blood and marrow transplantation, 2011-06, Vol.17 (6), p.935-940

2011

Link zum Volltext

Verfügbarkeit prüfen

Randomized trial of 8-week versus 12-week VNCOP-B plus G-CSF regimens as front-line treatment in elderly aggressive non-Hodgkin’s lymphoma patients

Annals of oncology, 2002-09, Vol.13 (9), p.1364-1369

2002

Link zum Volltext

Verfügbarkeit prüfen

Reduced-Intensity Conditioning Followed by Related Allografts in Hematologic Malignancies: Long-Term Outcomes Most Successful in Indolent and Aggressive Non-Hodgkin Lymphomas

Biology of blood and marrow transplantation, 2011-07, Vol.17 (7), p.1025-1032

2011

Link zum Volltext

Verfügbarkeit prüfen

The VIM3-AraC regimen followed by autologous stem cell transplantation in refractory or relapsing aggressive non-Hodgkin's lymphoma. A prospective study of 71 consecutive cases

Leukemia, 1999-02, Vol.13 (2), p.282-288

1999

Link zum Volltext

Verfügbarkeit prüfen

FLUDAP: Salvage Chemotherapy for Relapsed/Refractory Aggressive Non-Hodgkin's Lymphoma

Leukemia & lymphoma, 2000, Vol.37 (3-4), p.309-317

2000

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis C virus and lymphoma

Critical reviews in oncology/hematology, 2015-03, Vol.93 (3), p.246-256

Paydas, Semra

2015

Link zum Volltext

Verfügbarkeit prüfen

Baseline immunoglobulin G and immune function in non-Hodgkin lymphoma: a retrospective analysis

Frontiers in immunology, 2024-04, Vol.15, p.1334899-1334899

2024

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 58

Suche als RSS-Feed

Aktive Filter

ThemaLymphoma, Non-Hodgkin - Mortality

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(50)

Publikationsform

Artikel
(58)

Sprache

Englisch
(54)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

Humans
(58)
Life Sciences & Biomedicine
(50)
Science & Technology
(50)
Female
(45)
Male
(45)
Lymphoma, Non-Hodgkin - Drug Therapy
(44)
Middle Aged
(43)
Adult
(39)
Oncology
(37)
Aged
(35)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(35)
Hematology
(32)
Cyclophosphamide - Administration & Dosage
(25)
Prognosis
(24)
Adolescent
(23)
Treatment Outcome
(23)
Antineoplastic Combined Chemotherapy Protocols - Administration & Dosage
(22)
Biological And Medical Sciences
(22)
Medical Sciences
(22)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Pretransplantation [18‐F]fluorodeoxyglucose positron emission tomography scan predicts outcome in patients with recurrent Hodgkin lymphoma or aggressive non‐Hodgkin lymphoma undergoing reduced‐intensity conditioning followed by allogeneic stem cell transplantation

Serum-soluble tumor necrosis factor receptor 2 (sTNF-R2) level determines clinical outcome in patients with aggressive non-Hodgkin's lymphoma

Clinical characteristics and outcome of isolated extracerebral relapses of primary central nervous system lymphoma: a case series

A prospective study of P-IMVP-16/CBDCA: a novel salvage chemotherapy for patients with aggressive non-Hodgkin's lymphoma who had previously received CHOP therapy as first-line chemotherapy

Central nervous system occurrence in elderly patients with aggressive lymphoma and a long-term follow-up

Treatment of intermediate- and high-grade non-Hodgkin's lymphoma using CEOP versus CNOP

Autologous stem cell transplantation in first-line treatment of high-risk aggressive non-Hodgkin's lymphoma

Outcome of Elderly Patients with Aggressive Non-Hodgkin's Lymphoma Refractory to or Relapsing after First-line CHOP or CHOP-like Chemotherapy: A Low Probability of Cure

Impact of involved field radiotherapy in partial response after doxorubicin-based chemotherapy for advanced aggressive non-Hodgkin’s lymphoma

Frontline Therapy with Early Intensification and Autologous Stem Cell Transplantation versus Conventional Chemotherapy in Unselected High-Risk, Aggressive Non-Hodgkin’s Lymphoma Patients: A Prospective Randomized GEMOH Report

Midtreatment 18F‐fluorodeoxyglucose positron‐emission tomography in aggressive non‐Hodgkin lymphoma

The value of radiation therapy in the management of aggressive non-Hodgkin's lymphomas

Dose-dense therapy improves survival in aggressive non-Hodgkin’s lymphoma

Prognostic factors in localized aggressive non-Hodgkin's lymphoma

Treatment outcome in elderly patients with aggressive non-Hodgkin's lymphoma

High-dose therapy followed by stem cell transplantation in partial response after first-line induction therapy for aggressive non-Hodgkin's lymphoma

Allogeneic Stem Cell Transplantation for Patients with Relapsed Chemorefractory Aggressive Non-Hodgkin Lymphomas

Long-Term Follow-Up of Tandem High-Dose Therapy with Autologous Stem Cell Support for Adults with High-Risk Age-Adjusted International Prognostic Index Aggressive non-Hodgkin Lymphomas: A GOELAMS Pilot Study

Randomized trial of 8-week versus 12-week VNCOP-B plus G-CSF regimens as front-line treatment in elderly aggressive non-Hodgkin’s lymphoma patients

Reduced-Intensity Conditioning Followed by Related Allografts in Hematologic Malignancies: Long-Term Outcomes Most Successful in Indolent and Aggressive Non-Hodgkin Lymphomas

The VIM3-AraC regimen followed by autologous stem cell transplantation in refractory or relapsing aggressive non-Hodgkin's lymphoma. A prospective study of 71 consecutive cases

FLUDAP: Salvage Chemotherapy for Relapsed/Refractory Aggressive Non-Hodgkin's Lymphoma

Hepatitis C virus and lymphoma

Baseline immunoglobulin G and immune function in non-Hodgkin lymphoma: a retrospective analysis

Aktive Filter

Suchergebnisse filtern